Important notification
31.07.2012 To the attention of Marketing Authorisation Holders 1. Type IA and IB variations to MA terms or outside such […]
Important notification
19.07.2012 To the attention of Marketing Authorisation Holders The meeting of 23.07.2012 organised by the NAMMD with MAH representatives OUTSIDE […]
Important notification
18.07.2012 To the attention of Marketing Authorisation applicants and holders Implications of the new pharmacovigilance legislation for marketing authorisation applicants/holders. […]
Important notification
10.07.2012 To the attention of Marketing Authorisation Holders Questions about pharmacovigilance legislation and the manner of variations handling through national […]
Important notification
28.06.2012 To the attention of Marketing Authorisation Holders On Monday, 23.07.2012, the NAMMD organises a meeting with MAH representatives (members […]
Important notification
18.05.2012 To the attention of Marketing Authorisation Holders In the context of implementation of the new pharmacovigilance activity, interested pharmaceutical […]
Important notification
08.05.2012 To the attention of Marketing Authorisation Holders On the NAMMD website, under the heading “Medicinal products for human use/Pharmacovigilance/Special […]
Press release
07.05.2012 To the attention of interested parties Project launch: “NATIONAL E-LEARNING PLATFORM ON PHARMACEUTICAL REGULATION“ – co-financed from the Regional […]
Important notification
09.03.2012 To the attention of Marketing Authorisation Holders In the context of the implementation of the new pharmacovigilance legislation on […]
Important notification
09.03.2012 To the attention of interested persons The opinion of the National Agency for Medicines and Medical Devices concerning the […]